The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
CLINICAL SPECTRUM AND PROGNOSIS OF UVEAL MELANOMA BASED ON AGE AT PRESENTATION IN 8,033 CASES
Abstract
PURPOSE: To evaluate clinical features and life prognosis of uveal melanoma based on age at presentation. DESIGN: Retrospective, nonrandomized, interventional case series. RESULTS: Of 8,033 eyes with uveal melanoma, 106 (1%) were in young patients (≤20 years), 4,287 (53%) in mid adults (21-60 years), and 3,640 (45%) in older adults (>60 years). Based on age (young, mid adults, and older adults) at presentation, tumor epicenter was located in iris (21, 4, 2%; P < 0.0001), ciliary body (8, 5, and 7%; P = 0.0225), or choroid (71, 91, and 90%; P < 0.0001). Mean tumor diameter (10.2, 10.8, 11.5 mm; P < 0.0001), mean tumor thickness (5.0, 5.3, 5.7 mm; P < 0.0001), and extraocular extension (1, 2, and 4%; P = 0.0004) increased with age. Kaplan-Meier estimates of tumor-related metastasis at 3, 5, 10, and 20 years were 2%, 9%, 9%, and 20% in young patients (P < 0.011); 6%, 12%, 23%, and 34% in mid adults (P < 0.0001); and 11%, 19%, 28%, and 39% in older adults. Kaplan-Meier estimate of tumor-related death at 3, 5, 10, and 20 years were 0%, 2%, 5%, and 17% in young patients (P = 0.08); 3%, 6%, 11%, and 17% in mid adults (P < 0.001); and 7%, 11%, 16%, and 20% in older adults. CONCLUSION: Compared with mid adults and older adults, young patients manifested a higher proportion of iris melanoma. Compared with older adults, young and mid adults showed smaller melanoma basal dimension and lower tumor-related metastasis and death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Balch, C. M., Soong, S.-J., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3622 · Cited by 2,388
(2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.7.969 · Cited by 771
Metastasis of Uveal Melanoma Millimeter-by-Millimeter in 8033 Consecutive Eyes
Shields, C. L. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.208 · Cited by 626
Self-citation(2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.12.1639 · Cited by 621
Incidence of uveal melanoma in the United States: 1973–1997
Singh, A. D., & Topham, A. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00078-2 · Cited by 512
Strouse, J. J., Fears, T. R., Tucker, M. A., & Wayne, A. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.899 · Cited by 364
Diener-West, M. (1992) · Archives of Ophthalmology · doi:10.1001/archopht.1992.01080140101036 · Cited by 355
(1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(98)00039-7 · Cited by 260
Survival rates with uveal melanoma in the United States: 1973–1997
Singh, A. D., & Topham, A. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00077-0 · Cited by 250
PROGNOSIS OF MALIGNANT MELANOMAS OF THE CHOROID AND CILIARY BODY
Paul, E. V., Parnell, B. L., & Fraker, M. (1962) · International Ophthalmology Clinics · doi:10.1097/00004397-196206000-00007 · Cited by 219
Cited by
Jager, M. J., Shields, C. L., Cebulla, C. M., Abdel-Rahman, M. H., Grossniklaus, H. E., Stern, M.-H., Carvajal, R. D., Belfort, R. N., Jia, R., Shields, J. A., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0158-0 · Cited by 825
Self-citationUveal melanoma: relatively rare but deadly cancer
Kaliki, S., & Shields, C. L. (2017) · Eye · doi:10.1038/eye.2016.275 · Cited by 672
Self-citationCHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side Effects
Dalvin, L. A., Shields, C. L., Orloff, M., Sato, T., & Shields, J. A. (2018) · Retina · doi:10.1097/iae.0000000000002181 · Cited by 336
Self-citation
Metadata
- Authors
- Shields, C. L., Kaliki, S., Furuta, M., Mashayekhi, A., & Shields, J. A.
- Venue
- Retina
- Published
- 2012-07
- Volume
- 32
- Issue
- 7
- Pages
- 1363-1372
- ISSN
- 0275-004X (ISSN-L)
- OpenAlex
- W2026285612
- Cited by
- 323
- References
- 14
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CLINICAL SPECTRUM AND PROGNOSIS OF UVEAL MELANOMA BASED ON AGE AT PRESENTATION IN 8,033 CASES. https://app.cochat.ai/papers/10.1097/iae.0b013e31824d09a8
- The paper
- Shields, C. L., Kaliki, S., Furuta, M., Mashayekhi, A., & Shields, J. A. (2012). CLINICAL SPECTRUM AND PROGNOSIS OF UVEAL MELANOMA BASED ON AGE AT PRESENTATION IN 8,033 CASES. Retina. https://doi.org/10.1097/iae.0b013e31824d09a8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.